{"input_url":"https://www.nature.com/articles/s41467-025-66167-z","gnews_decode":"https://www.nature.com/articles/s41467-025-66167-z","http_status":200,"final_url":"https://www.nature.com/articles/s41467-025-66167-z","html_length":546331,"trafilatura_result":"ok","text_length":46553,"text_preview":"Abstract\nWe aimed to determine the effect of semaglutide on patients with acute large vessel occlusion (LVO) receiving endovascular therapy (EVT). In this phase 2, investigator-initiated, multicenter, prospective, randomized, open-label, blinded endpoint trial conducted in China, we recruited patien","verdict":"OK"}